e-miRgency : the new spin-off from C2N's research work
Founded in January 2024 and housed at C2N, this start-up aims to exploit a patented technology based on microfluidics and electrochemistry to detect nucleic acids in short sequences quickly, sensitively and without error compared with RT-qPCR. This technology is …
Read more...